MANCHESTER, United Kingdom--()--Intertek, a leading provider of quality and safety services to a wide range of industries around the world, will highlight how its unique blend of expert pharmaceuticals analysis, auditing, technical support and regulatory services are helping to save the industry material costs whilst raising the safety of its products and reliability of its supply chains at ICSE / CPhi, Madrid, Spain, 9-11 October 2012. Stand 10E89.
“ICSE is a perfect forum for preliminary discussions on strategic approaches to protein structure characterization which our clients in the biotechnology industry value so highly.”
ICSE connects the pharmaceutical and biopharmaceutical community with expert service providers to outsourcing for solutions to some of today’s toughest challenges, offering a forum for business development, networking and education.
Experts from Intertek Pharmaceutical Services will be available to meet with businesses during the event to share the experience of its history of successful innovative and tailored programmes. Covering a wide scope of services for both clinical development and product testing, such as GLP bioanalysis, GMP product analysis, auditing, method development validation and remediation, GMP microbiology, manufacturing technical support or sustainability consultancy, Intertek experts will be engaging on clients’ outsourcing needs for the year ahead and beyond.
Intertek will also have specialists in biopharmaceuticals characterization on hand to discuss tailored packages for GMP analytical support. Ashleigh Wake, Biotechnology Programme Manager said “ICSE is a perfect forum for preliminary discussions on strategic approaches to protein structure characterization which our clients in the biotechnology industry value so highly.”
“From how best to structure individual work packages, to releasing greater value from your laboratory assets under innovative partnering programmes through to helping your organization with its asset light expansion strategies overseas, our experts at ICSE look forward to reviewing our partnership experiences with you and to hearing of the specific challenges you currently face” said Dr. Andrew Swift, Executive Vice President of Intertek Chemical and Pharmaceutical Services “in some of the most challenging times the industry has faced, in pipeline development, consumer safety and regulation our success record of implementing flexible, economic, creative and global solutions is helping the leaders stay in front and we look forward to sharing that experience in our discussions with you at ICSE.”
Intertek is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers’ products and processes, supporting their success in the global marketplace. With a network of more than 1,000 laboratories and offices and over 33,000 people in more than 100 countries, Intertek helps its clients to meet end users’ expectations across increasingly diverse quality, health, environmental, safety and social accountability aspects in virtually any market around the world. Visit www.intertek.com